Research

Polycystic Ovary Syndrome Officially Renamed After 14-Year Study

Is renaming PCOS to PMOS a long-overdue win for millions of women or a costly distraction from real systemic failures?

Published MAY 12

Polycystic Ovary Syndrome Officially Renamed After 14-Year Study

Story

Above: Endocrinologist Helena Teede in Australia on Feb. 10, 2006. Image credit: Melanie Faith Dove/The Age/Getty Images

The Facts

Polycystic ovary syndrome (PCOS) has been officially renamed polyendocrine metabolic ovarian syndrome (PMOS) following a global consensus study published in The Lancet and announced on Tuesday at the European Congress of Endocrinology in Prague.
guardian
India Today
The renaming effort, led by Australian endocrinologist Helena Teede of Monash University's Centre for Health Research & Implementation, took 14 years and drew more than 22,000 survey responses from patients and health professionals across six continents.
KURIER
ABC Australia
A study of more than 1,200 Finnish women, published in JAMA Internal Medicine, found that women with PCOS did not have a higher rate of abnormal ovarian cysts than those without the condition, reportedly undermining a core implication of the former name.
The Lancet
RNZ
JAMA Network
PMOS affects about one in eight women — around 170 million people globally — and is associated with irregular periods, elevated androgen levels, insulin resistance, type 2 diabetes, cardiovascular disease and mental health conditions.
KURIER
University of Colorado Anschutz
The new name is intended to reflect the condition's hormonal and metabolic complexity, with "polyendocrine" referring to multiple hormone systems, "metabolic" addressing blood sugar and cardiovascular risks, and "ovarian" acknowledging reproductive impacts.
The Lancet
India Today
PCOS Challenge, the largest PCOS patient advocacy organization globally, said the renaming process "did not meet the evidentiary, ethical, and implementation standard required," arguing that a name change alone does not address training gaps, reimbursement structures or access to care.
RNZ
Prnewswire

Sources Split

LEFT

CENTER

RIGHT

ESTAB
CRIT

CENTER

PRO
ESTAB

The Spin

Narrative A

Renaming PCOS to PMOS is long overdue and a massive win for the 170 million women affected by this misunderstood condition. The old name caused real harm — doctors dismissed patients, missed diagnoses and reduced a complex hormonal disorder to a misleading focus on ovarian cysts. After 14 years of global collaboration across 56 medical and patient societies, this renaming finally reflects the full metabolic and endocrine reality of the condition.

guardian

Narrative B

Renaming PCOS without rigorous evidence that the name itself caused patient harm is a costly leap of faith. Delayed diagnoses and poor care stem from training gaps, reimbursement failures and research underinvestment — problems that a new acronym won't fix. The administrative adoption of PMOS risks disrupting the care networks, support communities and a research infrastructure that patients actually depend on.

Prnewswire